Publications dans lesquelles il/elle collabore avec DARIELA EDHIT MICHELOUD GIMÉNEZ (11)

2008

  1. Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection

    Transplant Infectious Disease, Vol. 10, Núm. 6, pp. 396-402

2007

  1. Chronic angioedema and blastocystis hominis infection

    Revista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú, Vol. 27, Núm. 2, pp. 191-193

  2. Hypocomplementemia in the absence of autoantibodies in women with recurrent pregnancy loss

    Allergologia et Immunopathologia, Vol. 35, Núm. 3, pp. 90-94

  3. Monitorización inmunológica en mujeres con aborto recurrente

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 34, Núm. 6, pp. 220-223

2006

  1. Antiphospholipid syndrome, hyperhomocysteinaemia and normocalcemic hyperparathyroidism

    Thrombosis and Haemostasis, Vol. 95, Núm. 5, pp. 900-901

  2. Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy

    Lupus, Vol. 15, Núm. 12, pp. 881-885

  3. Elevated levels of activated CD4 T cells in common variable immunodeficiency: Association with clinical findings

    Allergologia et Immunopathologia, Vol. 34, Núm. 4, pp. 131-135

  4. Enfermedad autoinmune sistémica en pacientes con uveítis

    Archivos de la Sociedad Española de Oftalmologia, Vol. 81, Núm. 4, pp. 193-198

2005

  1. Discordance between anti-β2-glycoprotein-I and anti-cardiolipin antibodies in patients with clinical criteria of antiphospholipid syndrome

    Clinical and Experimental Rheumatology, Vol. 23, Núm. 4, pp. 525-528

  2. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency

    Annals of the New York Academy of Sciences

2004

  1. Complement consumption associated with eczematous cutaneous reaction during infusions of high doses of intravenous immunoglobulin [11]

    British Journal of Dermatology